In August 2024, we decided to end Andwise, with no formal press release, no dramatic pivot tweets—just a resolve to shut it down before becoming something we never intended to.
Andwise began because we saw doctors like Ananya, a PGY-3 with looming student loan bills and no real legal training, about to sign her first job contract with all the subtle landmines hidden in the fine print. She could handle twelve-hour shifts and the emotional weight of patient care, but a contract’s tail coverage, non-competes, and moonlighting clauses were terrifyingly opaque. Her experience was common: most physicians step out of residency financially and legally disarmed. Meanwhile, their employers, lenders, and insurers know exactly how to exploit that knowledge gap.
We tried to build a platform that gave doctors actual clarity. We built a contract analyzer to highlight terms that could quietly lock them into bad deals. We brought in student loan tools to connect with servicers and surface better repayment or refinancing options. We tried to create a “Physician-Friendliness” score so they could avoid advisors who offered kickbacks rather than real guidance. To cap it off, we cultivated a growing network of free workshops, a newsletter called Fiscal Therapy, and a podcast we called Know Scrubs, so physicians could share insights with each other free from marketing agendas.
From the outset, we refused referral fees or sponsored placements. It wasn’t a branding tactic; it was because we believed doctors needed a truly unbiased tool. For a while, it worked. Residents said we were the first platform that actually helped them parse a contract in plain English. Some doctors saved hundreds a month on loan payments thanks to the dashboards we built.
And the feedback we got—hearing that a PGY-2 who was drowning in debt finally felt safe and informed—fed our conviction that we were filling a genuine gap.
But there’s an obvious cost to staying this brashly principled. We were lean to the point of running on fumes. Potential investors, though initially entranced by the “help doctors help themselves” mission, eventually wanted us to monetize fear. They suggested funneling anxious residents into tiered plans or pushing them toward whichever advisor gave us bigger affiliate fees. We sat in meetings where we were told we needed to “layer in urgency,” cut corners on transparency, and basically prey on the same vulnerability we were trying to protect.
Around the time these investor conversations grew more strained, I was also diagnosed as autistic. Suddenly, it felt even more impossible for me to compromise on tactics that manipulated users’ anxieties or “harvested” their trust in sneaky ways. It wasn’t just an ethical stance—it was how I was wired. The more we tried to blend standard startup growth strategies with our vow of neutrality, the more tension we created with our own existence.
At some point, I realized that sustaining Andwise on the usual venture track meant betraying the very reason we started. To keep going, we had to become something we promised not to be. Rather than cross that line, we shut down. We turned out the lights in August 2024, quietly, out of respect for what it had meant to the people who used it.
In the end, we didn’t scale. But we didn’t morph into another fear-based funnel, either. We helped hundreds of physicians understand contract terms, made it easier to ask tough financial questions, and gave them a place to speak honestly—without being sold to. Then we stopped on our own terms.
I don’t consider that a neat success story, nor do I see it as a clean failure. It’s a refusal story. In a system that monetizes illusions and thrives on short-lived trust, we simply said no.
And yes, it still hurts that Andwise is gone. I know doctors still desperately need what we tried to provide. The roadmap was real: from Match Day toolkits for interns to advanced financial planning for mid-career docs to a line of credit bridging the gap before a new resident’s first paycheck. We had a thorough vision of how doctors could keep more of their autonomy and break free from a system that preys on them. That vision just didn’t mesh with the typical growth demands that keep startups afloat.
So if you’re building a similarly principled venture, or if you’re a doctor who felt seen by what we did, I hope our story resonates. Sometimes, shutting down is the clearest way to stay true to your mission. We refused to become another manipulative pipeline in a broken landscape—and that refusal still feels like the right call.
If any piece of Andwise’s blueprint helps someone else carry the torch in a way that respects doctors’ intelligence and dignity, I’ll be cheering from the sidelines, still believing in what we started.
The joinandwise.com site will sunset soon. But the premise behind it—that clarity and care are still worth building for—lives on. Most of what I write at syadvada.com now zooms out: how systems filter and exclude, how trust is commodified, how design can either enable refusal or quietly remove it.
Andwise was my zoomed-in version of that same project. Not a critique. A counterexample.
- Kanav Jain Co-founder & CEO, Andwise (Closed August 2024)
Postscript, August 2026. A year and a half on, I'd tell this story with less romance and more structure. "Investors wanted us to monetize fear, so we refused" is true, but it compresses four separate facts. The product hypothesis held: physicians used Andwise and kept using it. The business model never resolved: adoption alone did not prove there was a way to finance the product that preserved what it was for. The monetization paths most likely to fund continued growth—tiered plans, referral fees, urgency mechanics—would have made physician fear the revenue engine and someone other than the physician the economic customer. And the shutdown was ultimately a capital-allocation decision, not a moral flourish: once the question stopped being "can we keep the company alive?" and became "what company would we have to become to keep it alive?", continuing was no longer justified.
The refusal framing above makes it sound like the system failed us. The structural version admits what I got wrong: I had assumed that if we created enough value for physicians, a compatible business model would eventually become available. It didn't follow. A product can create real value and still lack a financing structure that preserves the relationships that made it valuable—aligning the beneficiary, the user, and the economic buyer is a design problem in its own right, and it has to be solved before adoption makes the answer expensive. That lesson, more than the refusal, is what Andwise bought. The essay stands as written; this is what it looks like from further away.